Works matching IS 09612033 AND DT 2018 AND VI 27 AND IP 9

Results: 25

Simvastatin reduces antiphospholipid antibodies formation in patients with systemic lupus erythematosus: a preliminary study.

Published in:

2018

By:

Kotyla, P. J.

Publication type:

Letter to the Editor

A wolf in sheep's clothing.

Published in:

2018

By:

Chacko, B.;
Formby, M.

Publication type:

Letter to the Editor

Clinical and immunological pattern and outcome of Egyptian systemic lupus erythematosus patients: a single center experience.

Published in:

Lupus, 2018, v. 27, n. 9, p. 1562, doi. 10.1177/0961203318776085

By:

Mahmoud, G. A.;
Shahin, A. A.;
Zayed, H. S.;
Moghazy, A.;
Eissa, B. M.

Publication type:

Article

Klinefelter's syndrome with lupus encephalitis and retroperitoneal teratoma.

Published in:

2018

By:

W. Q., C. Ng;
Eide, S. E.;
J., Huang;
Y. M., Khor

Publication type:

Case Study

Microthrombotic renal involvement in an SLE patient with concomitant catastrophic antiphospholipid syndrome: the beneficial effect of rituximab treatment.

Published in:

Lupus, 2018, v. 27, n. 9, p. 1552, doi. 10.1177/0961203318768890

By:

Diószegi, Á.;
Tarr, T.;
Nagy-Vincze, M.;
Nánásy-Vass, M.;
Veisz, R.;
Bidiga, L.;
Dezsó, B.;
Balla, J.;
Szodoray, P.;
Szekanecz, Z.;
Soltész, P.

Publication type:

Article

Predictors of fracture risk in patients with systemic lupus erythematosus.

Published in:

Lupus, 2018, v. 27, n. 9, p. 1547, doi. 10.1177/0961203318768886

By:

Dey, M.;
Bukhari, M.

Publication type:

Article

Factors of the epidemiological triad that influence the persistence of human papilloma virus infection in women with systemic lupus erythematosus.

Published in:

Lupus, 2018, v. 27, n. 9, p. 1542, doi. 10.1177/0961203318773176

By:

Méndez-Martínez, S.;
García-Carrasco, M.;
Jiménez-Herrera, E. A.;
Mendoza-Pinto, C.;
Etchegaray-Morales, I.;
Barahona-Rubio, P. W.;
Gálvez-Romero, J. L.;
Munguía-Realpozo, P.;
Muñóz-Guarneros, C. O.;
Cedillo-Ramírez, M. L.;
Silva-Gómez, S. E.;
Linares-Fleites, G.;
Rojas-Vallaraga, A.

Publication type:

Article

Depression and medication nonadherence in childhood-onset systemic lupus erythematosus.

Published in:

Lupus, 2018, v. 27, n. 9, p. 1532, doi. 10.1177/0961203318779710

By:

Davis, A. M.;
Graham, T. B.;
Zhu, Y.;
McPheeters, M. L.

Publication type:

Article

Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onset.

Published in:

Lupus, 2018, v. 27, n. 9, p. 1479, doi. 10.1177/0961203318777112

By:

Sebastiani, G. D.;
Prevete, I.;
Iuliano, A.;
Piga, M;
Iannone, F.;
Coladonato, L.;
Govoni, M.;
Bortoluzzi, A.;
Mosca, M.;
Tani, C.;
Doria, A.;
Iaccarino, L.;
Tincani, A.;
Fredi, M.;
Conti, F.;
Spinelli, F. R.;
Galeazzi, M.;
Bellisai, F.;
Zanetti, A.;
Carrara, G.

Publication type:

Article

Plasma levels of β2-microglobulin are associated with atherosclerosis in patients with systemic lupus erythematosus: a cross-sectional cohort study.

Published in:

Lupus, 2018, v. 27, n. 9, p. 1517, doi. 10.1177/0961203318784661

By:

Leffers, H. C. B.;
Hermansen, M. L.;
Sandholt, B.;
Fuchs, A.;
Sillesen, H.;
Køber, L.;
Kofoed, K. F.;
Faurschou, M.;
Jacobsen, S.

Publication type:

Article

Increased serum leptin levels are associated with metabolic syndrome and carotid intima media thickness in premenopausal systemic lupus erythematosus patients without clinical atherosclerotic vascular events.

Published in:

Lupus, 2018, v. 27, n. 9, p. 1509, doi. 10.1177/0961203318782424

By:

Demir, S.;
Erten, G.;
Artım-Esen, B.;
Şahinkaya, Y.;
Pehlivan, Ö;
Alpay-Kanıtez, N.;
Deniz, G.;
Inanç, M.

Publication type:

Article

Decreased T cell expression of H/ACA box small nucleolar RNA 12 promotes lupus pathogenesis in patients with systemic lupus erythematosus.

Published in:

Lupus, 2018, v. 27, n. 9, p. 1499, doi. 10.1177/0961203318778362

By:

Lai, N.-S.;
Yu, H.-C.;
Huang, K.-Y.;
Tung, C.-H.;
Huang, H.-B.;
Lu, M.-C.

Publication type:

Article

A 6-month open-label extension study of the safety and efficacy of subcutaneous belimumab in patients with systemic lupus erythematosus.

Published in:

Lupus, 2018, v. 27, n. 9, p. 1489, doi. 10.1177/0961203318777634

By:

Doria, A.;
Bass, D.;
Schwarting, A.;
Hammer, A.;
Gordon, D.;
Scheinberg, M.;
Fox, N. L.;
Groark, J.;
Stohl, W.;
Kleoudis, C.;
Roth, D.

Publication type:

Article

Less than 7 hours of sleep per night is associated with transitioning to systemic lupus erythematosus.

Published in:

Lupus, 2018, v. 27, n. 9, p. 1524, doi. 10.1177/0961203318778368

By:

Young, K. A.;
Munroe, M. E.;
Harley, J. B.;
Guthridge, J. M.;
Kamen, D. L.;
Gilkensen, G. S.;
Weisman, M. H.;
Karp, D. R.;
Wallace, D. J.;
James, J. A.;
Norris, J. M.

Publication type:

Article

Rituximab-mediated late-onset neutropenia in systemic lupus erythematosus - distinct roles of BAFF and APRIL.

Published in:

Lupus, 2018, v. 27, n. 9, p. 1470, doi. 10.1177/0961203318777116

By:

Parodis, I.;
Söder, F.;
Faustini, F.;
Kasza, Z.;
Samuelsson, I.;
Zickert, A.;
Svenungsson, E.;
van Vollenhoven, R. F.;
Malmström, V.;
Wermeling, F.;
Gunnarsson, I.

Publication type:

Article

Evaluation of ATG5 polymorphisms in Italian patients with systemic lupus erythematosus: contribution to disease susceptibility and clinical phenotypes.

Published in:

Lupus, 2018, v. 27, n. 9, p. 1464, doi. 10.1177/0961203318776108

By:

Ciccacci, C.;
Perricone, C.;
Alessandri, C.;
Latini, A.;
Politi, C.;
Delunardo, F.;
Pierdominici, M.;
Conti, F.;
Novelli, G.;
Ortona, E.;
Borgiani, P.

Publication type:

Article

Histological predictors of renal outcome in lupus nephritis: the importance of tubulointerstitial lesions and scoring of glomerular lesions.

Published in:

Lupus, 2018, v. 27, n. 9, p. 1455, doi. 10.1177/0961203318776109

By:

Obrişcă, B.;
Jurubiţă, R.;
Andronesi, A;
Sorohan, B.;
Achim, C.;
Bobeica, R.;
Gherghiceanu, M.;
Mandache, E.;
Ismail, G.

Publication type:

Article

Revisiting the Phadia/EliA cut-off values for anticardiolipin and anti-β2-glycoprotein I antibodies: a systematic evaluation according to the guidelines.

Published in:

Lupus, 2018, v. 27, n. 9, p. 1446, doi. 10.1177/0961203318776105

By:

Bor, M. V.;
Jacobsen, I.-L. Søtang;
Gram, J. B.;
Sidelmann, J. J.

Publication type:

Article

Preconception antiphospholipid antibodies and risk of subsequent early pregnancy loss.

Published in:

Lupus, 2018, v. 27, n. 9, p. 1437, doi. 10.1177/0961203318776089

By:

Gibbins, K. J.;
Mumford, S. L.;
Sjaarda, L. A.;
Branch, D. W.;
Perkins, N. J.;
Ye, A.;
Schisterman, E. F.;
Silver, R. M.

Publication type:

Article

Early symptoms of systemic lupus erythematosus (SLE) recalled by 339 SLE patients.

Published in:

Lupus, 2018, v. 27, n. 9, p. 1431, doi. 10.1177/0961203318776093

By:

Leuchten, N.;
Milke, B.;
Winkler-Rohlfing, B.;
Daikh, D.;
Dörner, T.;
Johnson, S. R.;
Aringer, M.

Publication type:

Article

Epidemiology of cutaneous lupus erythematosus and the associated risk of systemic lupus erythematosus: a nationwide cohort study in Denmark.

Published in:

Lupus, 2018, v. 27, n. 9, p. 1424, doi. 10.1177/0961203318777103

By:

Petersen, M. Prütz;
Möller, S.;
Bygum, A.;
Voss, A.;
Bliddal, M.

Publication type:

Article

Severe brady-arrhythmias in systemic lupus erythematosus: prevalence, etiology and associated factors.

Published in:

Lupus, 2018, v. 27, n. 9, p. 1415, doi. 10.1177/0961203318770526

By:

Tselios, K.;
Gladman, D. D.;
Harvey, P.;
Su, J.;
Urowitz, M. B.

Publication type:

Article

Neurologic manifestations of antiphospholipid syndrome.

Published in:

Lupus, 2018, v. 27, n. 9, p. 1404, doi. 10.1177/0961203318776110

By:

Ricarte, I. F.;
Dutra, L. A.;
Abrantes, F. F.;
Toso, F. F.;
Barsottini, O. G. P.;
Silva, G. S.;
de Souza, A. W. S.;
Andrade, D.

Publication type:

Article

Hydroxychloroquine: an update.

Published in:

Lupus, 2018, v. 27, n. 9, p. 1402, doi. 10.1177/0961203318787040

By:

Hughes, G. R. V.

Publication type:

Article

Using hydroxychloroquine and protecting the retina.

Published in:

2018

By:

Schreiber, K.;
Davies, N.;
Hunt, B. J.

Publication type:

Editorial